SCHEMBL2609871

SCHEMBL2609871

CC1(C)c2cc(-c3c4ccccc4c(-c4cccc5ccccc45)c4ccccc34)ccc2-c2ccc3c4ccccc4n(-c4ccccc4)c3c21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33
TUBB8 Q3ZCM7 1/20 0.33
TUBA3E Q6PEY2 1/20 0.33
TUBA1A Q71U36 1/20 0.33
TUBA1C Q9BQE3 1/20 0.33
TUBB6 Q9BUF5 1/20 0.33
TUBB2B Q9BVA1 1/20 0.33
TUBB1 Q9H4B7 1/20 0.33
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18268526 0.91 L3MBTL1 (0.37) KDM4EATML3MBTL1MAPTPTGER4
SCHEMBL18268633 0.89 TUBB4A (0.33) KDM4EATML3MBTL1TUBB4ATUBB
SCHEMBL2609886 0.87 L3MBTL1 (0.41) KDM4EATML3MBTL1MAPTPTGER4
SCHEMBL18268597 0.87 KDM4E (0.34) KDM4EATML3MBTL1TUBB4ATUBB
SCHEMBL2609891 0.86 L3MBTL1 (0.41) KDM4EATML3MBTL1MAPTPTGER4
SCHEMBL2609882 0.85 KDM4E (0.41) KDM4EATML3MBTL1PTGER4DUSP3
SCHEMBL14685282 0.85 L3MBTL1 (0.40) KDM4EATML3MBTL1MAPTPTGER4
SCHEMBL2609852 0.85 KDM4E (0.37) KDM4EATML3MBTL1TUBB4ATUBB
SCHEMBL2609879 0.84 KDM4E (0.37) KDM4EATML3MBTL1DUSP3
SCHEMBL2609880 0.84 KDM4E (0.42) KDM4EATML3MBTL1DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9224961-B2 Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-29 US disclosed
US-9224961-B2 Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-29 US disclosed
US-20120097932-A1 CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 US disclosed
US-20120097932-A1 CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120097932-A1 CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE OCIAD1, OCIAD2, CFD KDM4E 3315/4885ATM 4310/4885L3MBTL1 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.